Annalisa Nobili Selected Research

Annalisa Nobili Research Topics

9	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 09/2013
4	Neuroinflammatory Diseases 01/2023 - 01/2019
4	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2017
2	Epilepsy (Aura) 01/2024 - 12/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2021
2	Gliosis 11/2020 - 03/2020
2	Cognitive Dysfunction 11/2020 - 01/2017
2	Seizures (Absence Seizure) 11/2019 - 12/2016
1	Autistic Disorder (Autism) 01/2023
1	Atrophy 01/2022
1	Prodromal Symptoms 11/2020
1	Glioma (Gliomas) 11/2019
1	Encephalitis (Encephalitis, Rasmussen) 11/2019
1	Memory Disorders (Memory Loss) 11/2019
1	Movement Disorders (Movement Disorder) 11/2019
1	Nervous System Diseases (Neurological Disorders) 11/2019
1	Nerve Degeneration 01/2019
1	Mood Disorders (Mood Disorder) 01/2017
1	Synucleinopathies 01/2017
1	Amyloidosis 12/2016
1	Body Weight (Weight, Body) 10/2015

6	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 12/2016
2	nilotinib FDA Link 04/2023 - 01/2021
2	SynucleinsIBA 01/2023 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 12/2016
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2020 - 03/2020
2	resolvin D1IBA 10/2019 - 01/2019
1	ParvalbuminsIBA 01/2024
1	InflammasomesIBA 01/2023
1	Estrogen ReceptorsIBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 11/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2020
1	Amyloid beta-PeptidesIBA 01/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 11/2019
1	AntibodiesIBA 11/2019
1	AutoantibodiesIBA 11/2019
1	Leucine (L-Leucine)FDA Link 11/2019
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2017
1	LithiumIBA 01/2017
1	Monovalent CationsIBA 01/2017
1	Dopamine Receptors (Dopamine Receptor)IBA 12/2016
1	Peptides (Polypeptides)IBA 12/2016
1	RNA Splicing FactorsIBA 10/2015
1	Donepezil (Aricept)FDA LinkGeneric 10/2013
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2013
1	CalcineurinIBA 09/2013